Bhubaneswar-based rural healthcare startup CureBay has raised about Rs 100 crore in a pre-Series C funding round led by IvyCap Ventures, as it plans to take its network of clinics to new states, including Andhra Pradesh.
/indianstartupnews/media/media_files/2026/06/17/desktop-728-x-90-1-2026-06-17-17-20-35.png)
The round comprises Rs 69 crore in equity from IvyCap Ventures and existing investors, and more than Rs 30 crore in debt from Trifecta Capital, Alteria Capital and VentureSoul Partners.
CureBay said the money will go towards expanding across India, strengthening its healthcare delivery network and building its technology and AI capabilities. That includes what it calls its Intelligence Layer, which is designed to support patient screening, health insights and clinical decision making.
“Rural Bharat doesn’t need another app; it needs a system that works end to end, from the Swasthya Mitra at the doorstep to the specialist in the city. This capital lets us take that operating system to more states and make our AI do the heavy lifting, so that every family gets the right care at the right time, close to home,” said Priyadarshi Mohapatra, founder and CEO of CureBay.
Vikram Gupta, founder and managing partner of IvyCap Ventures, said CureBay’s ability to combine technology with a strong on-ground healthcare network makes its model particularly compelling.
“We are excited to partner with CureBay as it scales its reach and continues to make quality healthcare more accessible to underserved communities across the country,” Gupta said.
From 250 clinics to 800
CureBay currently runs more than 250 tech-enabled clinics across seven states, including Odisha, Chhattisgarh, Jharkhand and Bihar.
In January 2023, CureBay was running 17 e-clinics across districts in Odisha. By May 2025, when it raised its Series B, it had more than 150 eClinics in Odisha and Chhattisgarh.
The clinics are backed by more than 1,800 Swasthya Mitras, or community health workers, 530 trained clinical staff, 230 doctor partners and over 210 partner hospitals and laboratories. The startup said, it has served more than 17 lakh patients and runs more than 400 health camps every month.
What CureBay does
Founded in 2021 by Priyadarshi Mohapatra, Shobhan Mahapatra and Sanjay Swain, CureBay brings primary healthcare to small towns and villages. Patients at its clinics get doctor consultations, often by video, along with medicines, diagnostic tests, surgery facilitation and annual health memberships.
The startup describes its model as a six-layer system. It combines IoT-enabled clinics, the Swasthya Mitra network, a connected digital platform, AI-powered screening and risk alerts, a 24/7 command centre and CureBay Kavach.
Kavach is a subscription programme meant to encourage preventive care, offering consultations and support for medicines, diagnostics and some hospitalisation-related costs. When CureBay first launched its membership programme, it was priced at Rs 599 a year, or under Rs 50 a month.
On the AI side, the startup is investing in GPUs and training its own models to screen patients and assess health risks. Its existing AI products cover skin conditions, dental health and haemoglobin screening.
CureBay also works with the government on healthcare delivery and has been named the healthcare partner for Samriddhi Kendra. The Samriddhi Kendra is a Department of Telecommunications initiative that uses BharatNet broadband to run single-window rural service centres.
The first one, opened in March 2026 at Umri village in Madhya Pradesh’s Guna district, offers telemedicine consultations and diagnostics through a Health ATM, along with education, farm advisory and financial services.
Funding so far
The founders started with about $1.5 million from angel investors. Elevar Equity led CureBay’s Series A in November 2022, and then put in Rs 60 crore of a Rs 61.8 crore ($7.5 million) Series A1 extension in January 2024, which made it the largest external shareholder.
In May 2025, CureBay raised $21 million in a Series B round led by Bertelsmann India Investments, with existing investor Elevar Equity and British International Investment, the UK’s development finance institution, taking part.
According to regulatory filings cited in reports at the time, Bertelsmann committed about Rs 94 crore, British International Investment Rs 34 crore and Elevar Rs 31 crore.
Before the latest round, CureBay had raised more than $34.6 million from investors including Bertelsmann India Investments, British International Investment and Elevar Equity, according to reports.
